Camposol Holding Ltd. reports First Quarter 2017 financial results
May 31, 2017 13:27 pm UTC| Business
During the 1Q-17, Camposol generated an EBITDA[1] of USD 9.8 million, 9.7% higher than the EBITDA reported the 1Q-16. EBITDA margin increased to 16.8% from 16.2% reported in 1Q-16. As of March 31st, 2017, Camposol's LTM...
Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 31, 2017 13:27 pm UTC| Business
Press Release Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% First approved US NDA for Nicox First topical ocular formulation of the antihistamine cetirizine U.S. ...
Camposol Holding Ltd. reports First Quarter 2017 financial results
May 31, 2017 13:27 pm UTC| Business
During the 1Q-17, Camposol generated an EBITDA[1] of USD 9.8 million, 9.7% higher than the EBITDA reported the 1Q-16. EBITDA margin increased to 16.8% from 16.2% reported in 1Q-16. As of March 31st, 2017, Camposol's LTM...
Camposol Holding Ltd. reports First Quarter 2017 financial results
May 31, 2017 13:27 pm UTC| Business
During the 1Q-17, Camposol generated an EBITDA[1] of USD 9.8 million, 9.7% higher than the EBITDA reported the 1Q-16. EBITDA margin increased to 16.8% from 16.2% reported in 1Q-16. As of March 31st, 2017, Camposol's LTM...
Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 31, 2017 13:26 pm UTC| Business
Press Release Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% First approved US NDA for Nicox First topical ocular formulation of the antihistamine cetirizine U.S. ...
Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 31, 2017 13:26 pm UTC| Business
Press Release Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% First approved US NDA for Nicox First topical ocular formulation of the antihistamine cetirizine U.S. ...
Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 31, 2017 13:26 pm UTC| Business
Press Release Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% First approved US NDA for Nicox First topical ocular formulation of the antihistamine cetirizine U.S. ...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight